BC-14-CG34_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, 2-[[5-chloro-2-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-2-propan-2-yloxyanilino]pyrimidin-4-yl]amino]-N-cyclobutylbenzenesulfonamide (Novartis, 59737629)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/59737629
Similar Terms
Downloads & Tools

Genes

26 genes differentially expressed following the BC-14-CG34_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RPS16 ribosomal protein S16 3.02305
GAPDH glyceraldehyde-3-phosphate dehydrogenase 2.9881
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 1.04786
TMSB10 thymosin beta 10 0.60984
MRPL52 mitochondrial ribosomal protein L52 0.427754
ZNF90 zinc finger protein 90 0.373857
RPS5 ribosomal protein S5 0.373857
MYL9 myosin, light chain 9, regulatory 0.274118
ZMAT4 zinc finger, matrin-type 4 0.269445
HMGA1 high mobility group AT-hook 1 0.259519
NT5C 5', 3'-nucleotidase, cytosolic 0.259519
TRAP1 TNF receptor-associated protein 1 0.256366
VPS4A vacuolar protein sorting 4 homolog A (S. cerevisiae) 0.230362
MVP major vault protein 0.230362
DAD1 defender against cell death 1 0.225037
MYL2 myosin, light chain 2, regulatory, cardiac, slow 0.214862

decreased expression

Symbol Name Standardized Value
NOMO2 NODAL modulator 2 -0.408063
TCP11L1 t-complex 11, testis-specific-like 1 -0.402337
DPH5 diphthamide biosynthesis 5 -0.317918
NME1-NME2 NME1-NME2 readthrough -0.259519
TMEM167A transmembrane protein 167A -0.2512
ANXA3 annexin A3 -0.241754
ATP6V1G1 ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 -0.241754
CEBPG CCAAT/enhancer binding protein (C/EBP), gamma -0.2282
FRMD5 FERM domain containing 5 -0.22136
YME1L1 YME1-like 1 ATPase -0.214862